A case for continuing tocilizumab beyond 12 months in giant cell arteritis?

Authors
Category Primary study
JournalRheumatology Advances in Practice
Year 2019
This article has no abstract
Epistemonikos ID: 2f729e1d98acfa7701cf2c5e706fe91fb50ea23a
First added on: Feb 11, 2025